Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that topical calcipotriol may safely and effectively treat mild-to-moderate patchy alopecia areata, with significant hair regrowth observed in the majority of participants over 12 weeks.

This study found that normal-mode ruby laser treatment significantly improved facial hirsutism and maintained results for at least 48 weeks, with repeated treatments enhancing clinical effects.

This review discusses the management of androgenic disorders in women, highlighting that treatment is generally more effective than recognized, though improvement may take weeks or months to appear.

This double-blind control study found that an ointment containing propolis (50%) and aloe vera (3%) led to significant improvement in 64.4% of patients with mild to moderate psoriasis over 12 weeks, compared to no significant improvement in the placebo group.

In this study, Bioactive Collagen Peptides supplementation increased hair follicle cell proliferation and improved hair thickness in healthy women over 16 weeks compared to a placebo.

In this study, 1.25 mg daily finasteride for 28 weeks showed minimal increase in hair density and thickness in normoandrogenic female pattern hair loss, but no significant clinical improvement was observed.

This study found that in Asian patients aged 12 and older with alopecia areata and significant hair loss, ritlecitinib showed clinical efficacy in improving hair regrowth and eyebrow and eyelash scores over 48 weeks, with an acceptable safety profile observed throughout.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

This study reports that a third of patients with SARS-CoV-2 infection developed acute telogen effluvium within three weeks, highlighting a notable pattern of early hair loss following COVID-19.

In this study, the addition of a SULT1A1 enzyme booster to daily 5% minoxidil treatment significantly increased hair regrowth in men with androgenic alopecia compared to minoxidil alone.

This study found that combining carboxytherapy with standard treatment for androgenetic alopecia in men significantly improved clinical outcomes and patient satisfaction compared to standard treatment alone over a 24-week period.

This case report highlights significant hair regrowth in a Malaysian woman with localized alopecia areata after intralesional triamcinolone acetonide treatment at a concentration of 5 mg/mL.

This study reports that intramuscular compound betamethasone may offer rapid, short-term reduction in hair shedding for patients with telogen effluvium, particularly within a week, but often requires repeated treatments; only mild side effects were observed.

This study found that topical minoxidil increases hair density more than placebo in both men and women with androgenetic alopecia, achieving about 21 additional hairs per cm² after 16 to 48 weeks, while oral and topical versions show similar efficacy but different side effects.

This case report described a one-year-old male husky dog with severe itching and skin lesions caused by Demodex canis, where treatment with Nexgard® and other supportive therapies over two weeks improved the dog's condition, indicating Nexgard® as a viable option for managing canine demodicosis.

This study observed that pooled analysis of LED caps increased hair density in patients with androgenetic alopecia compared to sham, achieving 28.5 more hairs per cm².

This study conducted at Baghdad Teaching Hospital found that topical applications of Ciprofloxacin and Clindamycin effectively reduced acne severity indices in patients with mild to moderate acne vulgaris over 12 weeks, with Ciprofloxacin showing a greater reduction in papules and pustules compared to Clindamycin.

This study found that among placebo-treated patients in the BRAVE-AA trials, the likelihood of spontaneous hair regrowth in untreated severe alopecia areata was low, with only a small percentage achieving significant scalp, eyebrow, or eyelash hair improvement over 36 weeks.

In this study, dutasteride was found to be effective and safe in treating androgenetic alopecia in men who did not respond to finasteride, with improvements observed in hair loss and quality over 24 weeks.

This study found that a hair tonic containing 1% teak leaf extract significantly increased hair growth and user satisfaction in men with androgenic alopecia after 24 weeks, without causing adverse effects, and was comparable to the standard treatment, minoxidil.

This case report from Veterinary Clinical Complex, Kurumbapet, India, described a kitten with superficial dermatophytosis caused by Microsporum spp., which was successfully treated using itraconazole syrup, cetirizine, and a liver-supportive syrup, achieving complete recovery by the third week without adverse effects.

This study found that a powder made from papaya seeds and celery leaves remained stable for 3 weeks when stored at room or cold temperatures, suggesting potential for hair health applications.

This study found that hydroxychloroquine was less effective than betamethasone oral mini pulse therapy in managing alopecia areata, with patients on hydroxychloroquine experiencing score increases and more relapses at 24 weeks, though adverse event rates were similar between the groups.

In this study, oral minoxidil at a dose of 1.25 mg/day for 24 weeks was examined as a sole treatment for androgenetic alopecia in 32 patients, including those who had not responded to prior topical minoxidil or oral finasteride therapies.

In this study, botulinum toxin type A injections reduced the severity of treatment-resistant scalp psoriasis in more patients compared to placebo over a 12-week period.

In a study on female Wistar rats, researchers found that a hair tonic containing a 7.5%:2% combination of talok and pare leaf extracts increased hair growth comparable to minoxidil, showing similar efficacy in promoting hair growth without significant statistical difference.

This study found that orally administering the CCR5 inhibitor Maraviroc improved hair loss in 4 out of 5 mice with alopecia areata and also reduced the development of the condition, evidenced by decreased CCR5+ T-cell infiltration in treated mice.

This study found that applying a growth factor cocktail including FGF9 with microneedling significantly increased hair density and diameter in patients with androgenetic alopecia, with similar results regardless of microneedle depths between 0.5 mm and 0.8 mm.

This study found that minoxidil sulfate enhanced hair growth in CRF-OE mice, with increased hair growth scores observed at 2 and 4 weeks after treatment.

In this study, sandalwood and rose absolute oils were found to accelerate hair regrowth and promote hair follicle development in a mice model over four weeks.